... non-small celllungcancer NEJM 1990, 323:940-945 Le Chavalier T, Arriagada R, Quoix E, et al: Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small celllung cancer: ... small celllung carcinoma Cancer 2005, 103:2118-2127 Rengan R, Rosenzweig KE, Venkatraman E, et al: Improved local control with higher doses of radiation in large-volume stage III non-small -cell lung ... dose-escalation study in patients with inoperable, locally advanced nonsmallcelllungcancer with helical tomotherapy and concurrent chemotherapy Cancer 2010, 116:241-50 Bral S, Duchateau M, De Ridder M,...
... contours are well superimposed onto the kVCT lungs, while before registration MVCT lung was substantially different from kVCT lung A qualitative goodness of lung superimposition obtained after elastic ... elastic registration direction of the left lung: while the rigidly realigned MVCT lung presented a lung volume systematically smaller than the initial kVCT lung volume, after elastic registration ... analysis of lung volumes, in terms of V E , C E and JAC for right and left lung respectively VE in absolute value was between 0.19% - 5.23% for right lung and between 0.01% - 6.82% for left lung, while,...
... morphological characteristics of permanent human small celllungcancercell lines J Cancer Res Clin Oncol 1987, 113:31-40 NCCN guidelines for small -cell lungcancer [http://www.nccn.org/ professionals/physician_gls/f_guidelines.asp] ... in lung cancer: small -cell lungcancer (SCLC) Int J Radiat Oncol Biol Phys 2008, 72:327-334 Roof KS, Fidias P, Lynch TJ, Choi NC: Radiation dose intensification in limited-stage small -cell lung ... limited-stage small celllung cancer: facts, questions, prospects Radiother Oncol 2000, 55:1-9 Murray N, Turrisi AT: A review of first-line treatment for small -cell lungcancer J Thorac Oncol...
... P: Estimating the world cancer burden: Globocan 2000 Int J Cancer 2001, 94:153-156 Non-small CellLungCancer Collaborative Group: Chemotherapy in non small celllung cancer: a meta-analysis ... Translational Medicine 2008, 6:65 Background Lungcancer remains the leading cause of cancer- related mortality in the western world Non-small celllungcancer (NSCLC) accounts for approximately ... cisplatin-teniposide in patients with advanced non-small -cell lungcancer The European Organization for Research and Treatment of CancerLungCancer Cooperative Group J Clin Oncol 1998, 16:2133-2141...
... may act as a risk marker of lungcancer in Taiwan Cancer 2003, 97:1558-1563 11 Klein F, Amin Kotb WF, Petersen I: Incidence of human papilloma virus in lungcancerLungCancer 2009, 65:13-18 12 ... HPVs in Asian lungcancer is 35.7% The authors concluded that HPV may be the second leading cause of lungcancer after cigarette smoking Although studies of viral-related lungcancer have been ... in about 20-25% of lung cancers [8] The most common strains found are HPV 16 and HPV 18, the same strains that are commonly found in cervical cancer More than 90% of lungcancer in Taiwanese...
... marker expression in tumor cells versus stromal cells in non small celllungcancer Clin Cancer Res 2007, 13:6649-57 World Health Organization: Histological Typing of Lung and Pleural Tumours Geneva, ... is required for cancercell growth PLoS One 2008, 3:e2557 Yanaihara N, Caplen N, Bowman E, et al: Unique microRNA molecular profiles in lungcancer diagnosis and prognosis CancerCell 2006, 9:189-98 ... non-small celllungcancer Clin Cancer Res 2008, 14:5220-7 Andersen S, Eilertsen M, Donnem T, et al: Diverging prognostic impacts of hypoxic markers according to NSCLC histology LungCancer 2010...
... metastatic breast cancer Br J Cancer 2006, 95(6):683-90 Cancer Research UK [http://www.cancerresearchuk.org] Cancer Help [http://www.cancerhelp.org.uk] Association for International Cancer Research ... Staging of small cell and non-small celllungcancer University of Iowa Virtual Hospital; 1999 Hopwood P, Stephens RJ: Symptoms at presentation for treatment in patients with lung cancer: Implications ... Research and Treatment of Cancer Quality-of-Life Questionnaire -Lung Cancer- 17 items; EQ-5D: EuroQoL-5 Dimensions; HRQL: Healthrelated Quality of Life; NSCLC: Non-Small CellLung Cancer; SF-36: Short-Form...
... non-small -cell lung cancer: a meta-analysis JAMA 2004, 292:470-84 Mattson KV, Abratt RP, ten Velde G, Krofta K: Docetaxel as neoadjuvant therapy for radically treatable stage III non-small -cell lung cancer: ... docetaxel/cisplatin in patients with advanced non-small -cell lung cancer: preliminary analysis of a multicenter, randomized phase III study Clin LungCancer 2003, 4:288-93 Lilenbaum RC, Herndon JE, List ... Holland JC, Green MR: Single-agent versus combination chemotherapy in advanced non-small -cell lung cancer: the cancer and leukemia group B (study 9730) J Clin Oncol 2005, 23:190-6 Heys SD, Hutcheon...
... Non-Small- CellLung Cancer: A Systematic Review and Pooled Analysis J Clin Oncol 2008, 26:1142-1147 15 Pfannschmidt J, Dienemann H: Surgical Treatment of Oligometastatic Non-Small CellLungCancerLung ... DD: Number of Metastatic Sites is a Strong Predictor of Survival in Patients with NonsmallCellLungCancer With or Without Brain Metastases Cancer 2009, 115:2930-2938 doi:10.1186/1748-717X-6-80 ... Basaki K, Abe Y, Aoki M, Kondo H, Hatayama Y, Nakaji S: Prognostic factors for survival in Stage III non-small -cell- lungcancer treated with definitive radiation therapy: impact of tumor volume IJROBP...
... stage I non-small celllung cancer: a 13-year analysis Ann Thorac Surg 2006, 82:408-415 Strand TE, Rostad H, Moller B, Norstein J: Survival after resection for primary lung cancer: a population ... Non-small CellLungCancer Int J Radat Oncol Biol Phys 2007, 69:S46-S47 Hiraoka M, Ishikura S: A Japan clinical oncology group trial for stereotactic body radiation therapy of non-small celllungcancer ... non-small cellLungcancer (ROSEL, ClinicalTrials.gov ID = NCT00687986) has been opened for accrual in August 2008 The study is initiated by the VU medical centre Amsterdam and the Dutch Lung Cancer...
... chemoradiotherapy for limited-disease small celllungcancer (Figure 1) The primary endpoint of JCOG 0202 was overall survival and the secondary endpoints included disease-free survival and the toxicity profile ... whether RT with carboplatin would result in longer survival than RT alone in elderly patients with unresectable stage III non-small celllung cancer; however, due to excessive serious adverse ... radiation therapy quality control on survival, response and sites of relapse in oat cell carcinoma of the lung: preliminary report of a Southwest Oncology Group study Cancer 1982, 50:1084-1090 Abrams...
... overall survivalrates are 78% and 56%, cancer specific survivalrates (CSS) are 90% and 74% (Figure 3), and local relapse free survivalrates are 93% and 76% respectively Median overall survival ... escalation in non-small -cell lungcancer Int J Radiat Oncol Biol Phys 2001, 49:23-33 Abratt RP, Bogart JA, Hunter A: Hypofractionated radiation for non-small celllungcancerLungCancer 2002, 36:225-33 ... non-small celllungcancer Int J Radiat Oncon Biol Phys 2002, 52:1047-57 Qiao X, Tullgren O, Lax I, Sirzen F, Lewensohn R: The role of radiation therapy in treatment of stage I non-small celllung cancer...
... chemoradiotherapy in non-small celllungcancer (Review) In The Cochrane Library Volume Wiley; 2005:1-37 Vokes EE: Optimal therapy for unresectable stage III nonsmall- celllungcancer J Clin Oncol 2005, ... stage I Nonsmallcelllung carcinoma Cancer 2004, 101:1623-1631 Belderbos J, Heemsbergen W, Hoogeman M, Pengel K, Rossi M, Lebesque J: Acute esophageal toxicity in non-small celllungcancer patients ... vinorelbine in patients with locally advanced non-small -cell lungcancer A phase II trial conducted by the Groupe Francais de PneumoCancerologie (GFPC) LungCancer 2005, 47:395-404 Vokes E, Herndon J, Kelley...